Skip to main content
Caplight Logo









SpheroTec GmbH

SpheroTec GmbH

Private
GermanyHealthcare & Life Scienceshttps://spherotec.com/

Last Round

Grant

Jan 1, 2017

Total Funding Raised

$1.47M

Company Overview

SpheroTec GmbH is a biotechnology company that provides three-dimensional cell culture systems for functional testing of drug candidates in oncology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

3D cell culturefunctional drug testingpersonalized therapyspheroid modeloncology diagnosticsdrug sensitivity testingin vitro oncologytumor microenvironmentcontract research organizationCROpatient-derived modelsorganoidprecision oncologypreclinical screeninglab-grown tumors

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SpheroTec GmbH Comparables

Compare SpheroTec GmbH with similar companies based on industry and business-model similarity.

SpheroTec GmbH comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Invitrocue
86%
Kiyatec
86%
2cureX
83%

SpheroTec GmbH Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJan 1, 2017
VC RoundSep 1, 2009
SeedMay 16, 2007

SpheroTec GmbH Investors

Notable investors and investment history

SpheroTec GmbH investors
InvestorRounds
Mey Capital MatrixSeed
European CommissionGrant
Bayern KapitalSeed
High-Tech GründerfondsSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 1, 2009

    Raised $4.35M in a VC Round.

  • May 16, 2007

    $820K raised from Mey Capital Matrix and others.

SpheroTec GmbH Filings

Explore SEC and related filing metadata, where available.

SpheroTec GmbH filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about SpheroTec GmbH's valuation, stock price, and market status.

Is SpheroTec GmbH a public or private company?

SpheroTec GmbH is a private company.

What is the current stock price of SpheroTec GmbH?

SpheroTec GmbH is a private company with no public stock price. No recent secondary market data is available.

How much is SpheroTec GmbH worth (valuation)?

Valuation information for SpheroTec GmbH is not publicly available.

Can I buy SpheroTec GmbH stock?

SpheroTec GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was SpheroTec GmbH's last funding round?

SpheroTec GmbH's most recent funding round was Grant on January 1, 2017.

Who are the main investors in SpheroTec GmbH?

Key investors in SpheroTec GmbH include Mey Capital Matrix, European Commission, Bayern Kapital, High-Tech Gründerfonds.

Will SpheroTec GmbH IPO soon?

No public IPO plans have been announced for SpheroTec GmbH.

How can I track SpheroTec GmbH secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor SpheroTec GmbH's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersGermany
Year Founded2006
Last FundingJan 1, 2017

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?